EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
M Weber, M Lam, C Chiesa, M Konijnenberg… - European journal of …, 2022 - Springer
Primary liver tumours (ie hepatocellular carcinoma (HCC) or intrahepatic
cholangiocarcinoma (ICC)) are among the most frequent cancers worldwide. However, only …
cholangiocarcinoma (ICC)) are among the most frequent cancers worldwide. However, only …
Recommendations for the management of yttrium-90 radioembolization in the treatment of patients with colorectal cancer liver metastases: a multidisciplinary review
E González-Flores, N Zambudio… - Clinical and …, 2024 - Springer
Purpose Strategies for the treatment of liver metastases from colon cancer (lmCRC) are
constantly evolving. Radioembolization with yttrium 90 (Y-90 TARE) has made significant …
constantly evolving. Radioembolization with yttrium 90 (Y-90 TARE) has made significant …
Yttrium-90 radioembolization dosimetry: what trainees need to know
A Villalobos, MM Soliman, BS Majdalany… - Seminars in …, 2020 - thieme-connect.com
Yttrium-90 radioembolization (Y90-RE), also known as transarterial radioembolization
(TARE) or selective internal radiation therapy (SIRT), is a form of brachytherapy that has …
(TARE) or selective internal radiation therapy (SIRT), is a form of brachytherapy that has …
Predictive factors for adverse event outcomes after transarterial radioembolization with yttrium-90 resin microspheres in Europe: results from the prospective …
G Maleux, T Albrecht, D Arnold, I Bargellini… - Cardiovascular and …, 2023 - Springer
Background Using data collected in the prospective observational study CIRSE Registry for
SIR-Spheres Therapy, the present study aimed at identifying predictors of adverse events …
SIR-Spheres Therapy, the present study aimed at identifying predictors of adverse events …
Determination of tumor dose response thresholds in patients with chemorefractory intrahepatic cholangiocarcinoma treated with resin and glass-based Y90 …
B Cheng, A Villalobos, I Sethi, W Wagstaff… - CardioVascular and …, 2021 - Springer
Purpose To compare the efficacies of glass and resin-based Yttrium-90 microspheres by
comparing absorbed tumor dose (TD) with both tumor response (TR) and overall survival …
comparing absorbed tumor dose (TD) with both tumor response (TR) and overall survival …
AAPM medical physics practice guideline 14. a: Yttrium‐90 microsphere radioembolization
NC Busse, MSAL Al‐Ghazi… - Journal of applied …, 2024 - Wiley Online Library
Abstract Radioembolization using Yttrium‐90 (90Y) microspheres is widely used to treat
primary and metastatic liver tumors. The present work provides minimum practice guidelines …
primary and metastatic liver tumors. The present work provides minimum practice guidelines …
Conventional hepatic volumetry may lead to inaccurate segmental yttrium-90 radiation dosimetry
SI Stein, MM Soliman, J Sparapani, R Doustaly… - CardioVascular and …, 2021 - Springer
Objective To compare radioembolization treatment zone volumes from mapping cone beam
CT (CBCT) versus planning CT/MRI and to model their impact on dosimetry. Methods Y90 …
CT (CBCT) versus planning CT/MRI and to model their impact on dosimetry. Methods Y90 …
Evaluation of results after 112 radioembolizations with 90y-microspheres
I Casáns-Tormo, J Guijarro-Rosaleny… - Revista Española de …, 2023 - Elsevier
Aim To determine the results of radioembolization transarterial (TARE), in the treatment of
liver tumors, a retrospective evaluation was performed after 112 TARE with 90 Y …
liver tumors, a retrospective evaluation was performed after 112 TARE with 90 Y …
Role of resin microsphere Y90 dosimetry in predicting objective tumor response, survival and treatment related toxicity in surgically unresectable colorectal liver …
Simple Summary Colorectal liver metastases are difficult to treat, with only a minority of
patients eligible for surgical resection. Yttrium-90 selective internal radiation therapy is an …
patients eligible for surgical resection. Yttrium-90 selective internal radiation therapy is an …
Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation. Part two: noncurative intention
Locoregional therapies can be offered to hepatocellular carcinoma patients as a bridge to
transplant, to downstage disease burden for transplant eligibility, or for disease control to …
transplant, to downstage disease burden for transplant eligibility, or for disease control to …